OIS@AAO 2016 Videos

Zadno, Rajpal Discuss Leadership Change, New Studies on PiXL

By Tom Salemi | November 8, 2016

Newly appointed CEO Reza Zadno, PhD, explains why he found Avedro to be such a promising opportunity. Rajesh Rajpal, MD, Chief Medical Officer, discusses two…

Read More
Nancy-Lurker

Lurker Says pSivida Has “Tremendous Opportunity”

By Mario Admin | November 8, 2016

Nancy Lurker explains why she took over as CEO and president at pSivida and gives details on the company’s “outstanding” results of early clinical testing…

Read More
Barry Cheskin

PowerVision’s Cheskin Delivers 20/20 Update

By Mario Admin | November 8, 2016

Barry Cheskin, co-founder, president, and CEO of PowerVision Inc., delivers an update on the company’s next iteration of IOL, Fluidvision 2020. Cheskin tells OIS-TV the…

Read More

Sensimed CEO Discloses Financing, Next Steps

By Mario Admin | November 8, 2016

Sensimed CEO David Bailey recounts his maiden presentation to OIS and shares information on the company’s recent financing, including a commitment from a new strategic…

Read More

InnFocus

By Mario Admin | November 8, 2016

InnFocus, a Santen company, is pioneering novel surgical solutions for treating glaucoma. The company is positioned to be the first FDA approved minimally invasive stand-alone…

Read More

Dempsey Details Shire’s Xiidra Strategy

By Mario Admin | October 31, 2016

Robert Dempsey, head of the ophthalmics franchise for Shire, lays out how Shire rolled out the commercial launch of Xiidra, the company’s new potential blockbuster…

Read More

How Will SightLife Surgical Fill the Cornea Gap?

By Mario Admin | October 26, 2016

Monty Montoya, CEO, introduces SightLife Surgical, the for-profit subsidiary of SightLife that he says will enable the group to complete its mission of eliminating treatable…

Read More

Catch Up on OIS@AAO’s Year in Review

By Mario Admin | October 20, 2016

OIS Co-Chair Emmett T. Cunningham Jr., MD, PhD, MPH laid out hopeful – and cautionary – signs facing the ophthalmology industry as he kicked off…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.